Beauty Health Co (SKIN) Financial Statements (2025 and earlier)

Company Profile

Business Address 2165 SPRING STREET
LONG BEACH, CA 90806
State of Incorp. DE
Fiscal Year End December 31
Industry (SIC) 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) ($ in thousands)

6/30/2025
MRQ
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments  523,025568,197901,8863,265
Cash and cash equivalent  523,025568,197901,8863,265
Receivables28,46155,02977,77451,423 
Inventory, net of allowances, customer advances and progress billings69,11391,321116,43035,261 
Inventory69,11391,321116,43035,261 
Prepaid expense     638
Other undisclosed current assets379,55028,87726,69812,322 
Total current assets:477,124698,252789,0991,000,8923,903
Noncurrent Assets
Operating lease, right-of-use asset13,59012,12015,63714,992 
Long-term investments and receivables     460,098
Long-term investments     460,098
Intangible assets, net (including goodwill)171,011187,941170,979179,704 
Goodwill123,499125,818124,593123,694 
Intangible assets, net (excluding goodwill)47,51262,12346,38656,010 
Deferred income tax assets3,894531815330 
Other noncurrent assets14,08616,04314,1936,705 
Other undisclosed noncurrent assets5,97814,22618,18416,183 
Total noncurrent assets:208,559230,861219,808217,914460,098
TOTAL ASSETS:685,683929,1131,008,9071,218,806464,001
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities41,94364,61445,51872,725765
Taxes payable292 
Employee-related liabilities28,66212
Accounts payable21,94144,76830,33529,049 
Accrued liabilities20,00219,84615,18314,722754
Other undisclosed current liabilities26,20950,39427,5973,712 
Total current liabilities:68,152115,00873,11576,437765
Noncurrent Liabilities
Long-term debt and lease obligation552,198738,372734,143742,695 
Long-term debt, excluding current maturities552,198738,372734,143729,914 
Liabilities, other than long-term debt13,04214,78814,7003,56116,100
Accounts payable and accrued liabilities  2,000   
Deferred compensation liability, classified     16,100
Deferred income tax liabilities3967022,0113,561 
Other liabilities1,8332,767   
Operating lease, liability10,8139,31912,68912,781 
Other undisclosed noncurrent liabilities4881,55515,47393,81665,647
Total noncurrent liabilities:565,728754,715764,316840,07281,747
Total liabilities:633,880869,723837,431916,50982,512
Temporary equity, including noncontrolling interest     376,489
Equity
Equity, attributable to parent, including:51,80359,390171,476302,2975,000
Common stock12121416 
Additional paid in capital566,709541,281550,320722,25043,912
Accumulated other comprehensive loss(6,953)(3,036)(4,530)(1,257) 
Accumulated deficit(507,965)(478,867)(374,328)(418,712)(38,914)
Other undisclosed equity, attributable to parent     2
Total equity:51,80359,390171,476302,2975,000
TOTAL LIABILITIES AND EQUITY:685,683929,1131,008,9071,218,806464,001

Income Statement (P&L) ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Revenues334,294397,991365,876260,086 
Cost of revenue(151,998)(242,878)(115,536)(78,259) 
Cost of product and service sold(28,041)(18,272)   
Gross profit:182,296155,113250,340181,827 
Operating expenses(250,070)(286,030)(274,620)(218,466) 
Operating loss:(67,774)(130,917)(24,280)(36,639) 
Nonoperating income (expense)45,56930,758(4,814)(340,711) 
Investment income, nonoperating16,64423,173   
Gain (loss), foreign currency transaction, before tax(4,638)2,385(3,164)(69) 
Other nonoperating income (expense)33,5635,200(1,650)(4,450) 
Interest and debt expense(10,412)(13,649) (2,300) 
Loss from continuing operations before equity method investments, income taxes:(32,617)(113,808)(29,094)(379,650) 
Other undisclosed income from continuing operations before income taxes3,06711,91974,1262,300 
Income (loss) from continuing operations before income taxes:(29,550)(101,889)45,032(377,350) 
Income tax expense (benefit)4521,773(648)2,242 
Income (loss) from continuing operations:(29,098)(100,116)44,384(375,108) 
Loss before gain (loss) on sale of properties:(375,108)
Net income (loss) available to common stockholders, basic:(29,098)(100,116)44,384(375,108) 
Dilutive securities, effect on basic earnings per share(22,671)    
Other undisclosed net loss available to common stockholders, diluted   (78,343)  
Net loss available to common stockholders, diluted:(51,769)(100,116)(33,959)(375,108) 

Comprehensive Income ($ in thousands)

6/30/2025
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Net income (loss):(29,098)(100,116)44,384(375,108) 
Comprehensive income (loss):(29,098)(100,116)44,384(375,108) 
Other undisclosed comprehensive income (loss), net of tax, attributable to parent(3,917)1,494(3,273)(1,499) 
Comprehensive income (loss), net of tax, attributable to parent:(33,015)(98,622)41,111(376,607) 

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: